PROCAINE HYDROCHLORIDE AS A MONOAMINE-OXIDASE INHIBITOR - IMPLICATIONS FOR GERIATRIC THERAPY

被引:3
作者
FULLER, RW [1 ]
ROUSH, BW [1 ]
机构
[1] ELI LILLY & CO,LILLY RES LAB,INDIANAPOLIS,IN 46206
关键词
D O I
10.1111/j.1532-5415.1977.tb00237.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:90 / 93
页数:4
相关论文
共 19 条
[1]  
ASLAN A, 1962, MEDICAL CLINICAL ASP
[3]  
FULLER RW, 1968, ARCH INT PHARMACOD T, V174, P32
[4]  
FULLER RW, 1972, ARCH INT PHARMACOD T, V198, P270
[5]  
FULLER RW, IN PRESS
[6]  
HRACHOVEC JP, 1974, FED PROC, V33, P460
[7]  
HRACHOVEC JP, 1973, GERONTOLOGIST, V13, P62
[8]  
HRACHOVEC JP, 1972, P GERONTOL SOC, V25, P31
[9]  
MACFARLA.MD, 1974, FED PROC, V33, P577
[10]   POSSIBLE RATIONAL FOR PROCAINE (GEROVITAL H-3) THERAPY IN GERIATRICS - INHIBITION OF MONOAMINE-OXIDASE [J].
MACFARLANE, MD .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1973, 21 (09) :414-418